BENITEC BIOPHARMA INC (BNTC) Forecast, Price Target & Analyst Ratings

NASDAQ:BNTC • US08205P2092

Current stock price

11.42 USD
+0.41 (+3.72%)
At close:
11.42 USD
0 (0%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for BENITEC BIOPHARMA INC (BNTC).

Forecast Snapshot

Consensus Price Target

Price Target
$26.11
+ 128.65% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 12, 2026
Period
Q3 / 2026
EPS Estimate
-$0.28
Revenue Estimate
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
87.69%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$26.11
Upside
+ 128.65%
From current price of $11.42 to mean target of $26.11, Based on 13 analyst forecasts
Low
$18.18
Median
$24.48
High
$33.60

Price Target Revisions

1 Month
1.59%
3 Months
1.59%

Price Target Summary

13 Wall Street analysts provided a forecast for the next 12 months for BNTC. The average price target is 26.11 USD. This implies a price increase of 128.65% is expected in the next year compared to the current price of 11.42.
The average price target has been revised upward by 1.59% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

BNTC Current Analyst RatingBNTC Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4 5

Analyst Ratings History

BNTC Historical Analyst RatingsBNTC Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Analyst Ratings Consensus

ChartMill Buy Consensus
87.69%
BNTC was analyzed by 13 analysts. The buy percentage consensus is at 88. So analysts seem to be very confident about BNTC.
In the previous month the buy percentage consensus was at a similar level.
BNTC was analyzed by 13 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-03-09HC Wainwright & Co.Reiterate Buy -> Buy
2025-11-24HC Wainwright & Co.Maintains Buy -> Buy
2025-11-04CitizensMaintains Market Outperform -> Market Outperform
2025-11-04HC Wainwright & Co.Maintains Buy -> Buy
2025-09-24JMP SecuritiesReiterate Market Outperform -> Market Outperform
2025-09-16OppenheimerMaintains Outperform -> Outperform
2025-05-19HC Wainwright & Co.Reiterate Buy -> Buy
2025-05-15JMP SecuritiesReiterate Market Outperform -> Market Outperform
2025-04-10JMP SecuritiesMaintains Market Outperform -> Market Outperform
2025-03-24HC Wainwright & Co.Reiterate Buy -> Buy
2025-03-18Citizens Capital MarketsReiterate Market Outperform -> Market Outperform
2025-02-21HC Wainwright & Co.Reiterate Buy -> Buy
2024-12-13BairdInitiate Outperform
2024-12-03GuggenheimReiterate Buy -> Buy
2024-10-16OppenheimerInitiate Outperform
2024-10-14JMP SecuritiesMaintains Market Outperform -> Market Outperform
2024-09-30JMP SecuritiesReiterate Market Outperform -> Market Outperform
2024-09-12GuggenheimInitiate Buy
2024-07-22Leerink PartnersInitiate Outperform
2024-06-13Piper SandlerInitiate Overweight
2024-04-22JMP SecuritiesMaintains Market Outperform -> Market Outperform
2024-02-15JMP SecuritiesMaintains Market Outperform -> Market Outperform
2024-01-24JMP SecuritiesMaintains Market Outperform -> Market Outperform
2023-09-26JMP SecuritiesMaintains Market Outperform -> Market Outperform
2023-06-26JMP SecuritiesReiterate Market Outperform -> Market Outperform

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 12, 2026
Period
Q3 / 2026
EPS Estimate
-$0.28
Revenue Estimate
Revenue Q2Q
N/A
EPS Q2Q
-16.73%
Number of Analysts
8

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
0.00%
EPS (3 Months)
0.30%

Next Earnings Summary

BNTC is expected to report earnings on 5/12/2026. The consensus EPS estimate for the next earnings is -0.28 USD and the consensus revenue estimate is 0 USD.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2028

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2021 2022 2023 2024 2025 2026 2027 2028
Revenue
YoY % growth
BNTC revenue by date.BNTC revenue by date.
60K
-40.00%		70K
16.67%		80K
14.29%
-100.00%		18.581M34.36M
84.92%
EBITDA
YoY % growth
BNTC ebitda by date.BNTC ebitda by date.
N/AN/AN/A
-4.82%		-25.092M
-26.23%		-26.112M
-86.13%		-36.248M
13.07%		10.997M
130.34%		N/A
EBIT
YoY % growth
BNTC ebit by date.BNTC ebit by date.
-13.6M
-64.25%		-17.85M
-31.25%		-19.08M
-6.89%		-22.739M
-17.87%		-35.847M
-85.70%		-52.707M
-26.20%		-67.526M
-28.12%		-50.19M
25.67%
Operating Margin
BNTC operating margin by date.BNTC operating margin by date.
-22,666.67%-25,500.00%-23,850.00%N/AN/AN/A-363.42%-146.07%
EPS
YoY % growth
BNTC eps by date.BNTC eps by date.
-3.21
43.56%		-1.02
68.18%		-16.94
-1,561.08%		-5.32
50.66%		-1.27
82.42%		-1.15
21.59%		-1.15-0.90
21.83%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth		-0.28
-16.73%		-0.30
28.84%		-0.32
-43.73%		-0.33
-26.84%		-0.21
23.54%		-0.01
96.59%
Revenue
Q2Q % growth		9.282M27.846M
EBITDA
Q2Q % growth		N/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth		-14.119M
-38.59%		-15.043M
12.42%		-15.13M
-54.34%		-15.887M
-18.76%		-16.68M
-18.14%		-17.514M
-16.43%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

BNTC Yearly Revenue VS EstimatesBNTC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2027 2028 10M 20M 30M
BNTC Yearly EPS VS EstimatesBNTC Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 -10 -20 -30

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
11.52%
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

BENITEC BIOPHARMA INC / BNTC Forecast FAQ

What is the price target for BNTC stock?

13 analysts have analysed BNTC and the average price target is 26.11 USD. This implies a price increase of 128.65% is expected in the next year compared to the current price of 11.42.

When does BENITEC BIOPHARMA INC (BNTC) report earnings?

BENITEC BIOPHARMA INC (BNTC) will report earnings on 2026-05-12.

Can you provide the consensus estimates for BENITEC BIOPHARMA INC next earnings?

The consensus EPS estimate for the next earnings of BENITEC BIOPHARMA INC (BNTC) is -0.28 USD and the consensus revenue estimate is 0 USD.